Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹10,137 Cr
Revenue (TTM)
₹6,538 Cr
Net Profit (TTM)
₹207 Cr
ROE
9.2 %
ROCE
18.2 %
P/E Ratio
49
P/B Ratio
5.3
Industry P/E
41.94
EV/EBITDA
15
Div. Yield
0 %
Debt to Equity
0
Book Value
₹158.5
EPS
₹17.3
Face value
2
Shares outstanding
120,054,642
CFO
₹1,071.74 Cr
EBITDA
₹2,041.36 Cr
Net Profit
₹526.68 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medplus Health
| 4.1 | -0.7 | 3.4 | 21.0 | 2.9 | -- | -- |
|
BSE Healthcare
| -3.2 | -2.9 | -3.2 | 3.9 | 25.0 | 15.7 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Medplus Health
| -4.9 | 12.2 | 22.4 | -40.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medplus Health
|
840.7 | 10,137.4 | 6,537.7 | 207.0 | 4.6 | 11.5 | 49 | 5.3 |
| 87.0 | 31.7 | 54.6 | -1.1 | 3.6 | -3.5 | -- | 1.1 | |
| 62.0 | 31.4 | 150.3 | -2.2 | -0.6 | -4.8 | -- | 0.6 | |
| 1,621.7 | 26,813.3 | 6,112.8 | 847.2 | 17.2 | 9.2 | 31.7 | 2.7 | |
| 173.7 | 954.4 | 264.6 | 19.3 | 8.9 | 6.2 | 41.2 | 4.1 | |
| 17.5 | 9.6 | 7.3 | 0.6 | 10.6 | 47.6 | 16.4 | 6.1 | |
| 1,247.3 | 12,739.9 | 1,781.6 | 341.3 | 19.8 | 12.4 | 36.6 | 4.3 | |
| 116.0 | 42.8 | 20.6 | 2.5 | 18.7 | 16.9 | 17.2 | 2.6 | |
| 186.6 | 992.8 | 414.3 | 20.3 | 8.0 | 3.4 | 48.8 | 1.6 |
MedPlus Health Services IPO: How good is it?
5 min read•By Danish Khanna
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical... devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India. Read more
Incorporated
2006
Chairman
Gangadi Madhukar Reddy
Managing Director
Gangadi Madhukar Reddy
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Medplus Health Services Ltd.’s IPO? Explore our IPO Details page.
The share price of Medplus Health Services Ltd is ₹840.65 (NSE) and ₹840.65 (BSE) as of 19-Mar-2026 11:14 IST. Medplus Health Services Ltd has given a return of 2.86% in the last 3 years.
The P/E ratio of Medplus Health Services Ltd is 48.97 times as on 19-Mar-2026, a 17 premium to its peers’ median range of 41.94 times.
The P/B ratio of Medplus Health Services Ltd is 5.33 times as on 19-Mar-2026, a 91 premium to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
60.48
|
5.30
|
|
2024
|
125.87
|
5.33
|
|
2023
|
156.11
|
5.32
|
|
2022
|
125.80
|
8.57
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Medplus Health Services Ltd are Rs 1,045.30 and Rs 678.05 as of 19-Mar-2026.
Medplus Health Services Ltd has a market capitalisation of ₹ 10,137 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Medplus Health Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.